Pages that link to "Q40548309"
Jump to navigation
Jump to search
The following pages link to Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial (Q40548309):
Displaying 50 items.
- Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis (Q26740313) (← links)
- New advances in hepatocellular carcinoma (Q26749329) (← links)
- Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function (Q28066295) (← links)
- Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis? (Q28068710) (← links)
- Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma (Q28070762) (← links)
- First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation (Q28073654) (← links)
- Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition (Q28077829) (← links)
- Local ablative treatments for hepatocellular carcinoma: An updated review (Q28078113) (← links)
- Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients (Q28079328) (← links)
- Virus-induced hepatocellular carcinoma with special emphasis on HBV. (Q30238961) (← links)
- Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis (Q30241048) (← links)
- Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review (Q33567018) (← links)
- Radiation therapy for hepatobiliary malignancies (Q33593244) (← links)
- A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein (Q33595138) (← links)
- New knowledge of the mechanisms of sorafenib resistance in liver cancer (Q33759933) (← links)
- Evolving role of Sorafenib in the management of hepatocellular carcinoma. (Q33779864) (← links)
- A new Prenylated Flavonoid induces G0/G1 arrest and apoptosis through p38/JNK MAPK pathways in Human Hepatocellular Carcinoma cells (Q33915816) (← links)
- Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial (Q36184640) (← links)
- High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection (Q36253066) (← links)
- Adjuvant sorafenib for liver cancer: wrong stage, wrong dose (Q36739406) (← links)
- Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy (Q36993423) (← links)
- Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients (Q37012378) (← links)
- Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients (Q37012707) (← links)
- pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma (Q37449500) (← links)
- Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B (Q37536593) (← links)
- Novel implications in the treatment of hepatocellular carcinoma (Q37542835) (← links)
- Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine (Q37562355) (← links)
- Prediction of early hepatocellular carcinoma recurrence using germinal center kinase-like kinase (Q37580314) (← links)
- From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers (Q37631655) (← links)
- Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection (Q37725279) (← links)
- Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial (Q38372397) (← links)
- Evaluating the current surgical strategies for hepatocellular carcinoma (Q38630530) (← links)
- Chemotherapy for hepatocellular carcinoma: The present and the future (Q38639762) (← links)
- Curative therapies for hepatocellular carcinoma: an update and perspectives (Q38640531) (← links)
- Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma (Q38660714) (← links)
- Regorafenib: a newly approved drug for advanced hepatocellular carcinoma. (Q38671174) (← links)
- Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma (Q38671883) (← links)
- Advances in Local and Systemic Therapies for Hepatocellular Cancer (Q38697243) (← links)
- Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter (Q38707438) (← links)
- Antiangiogenic therapy in oncology: current status and future directions (Q38725587) (← links)
- Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. (Q38726039) (← links)
- Clinical trials of antiangiogenic therapy for hepatocellular carcinoma (Q38743040) (← links)
- Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection (Q38758158) (← links)
- A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma. (Q38773911) (← links)
- MetastamiRs: A promising choice for antihepatocellular carcinoma nucleic acid drug development (Q38823802) (← links)
- Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C. (Q38830251) (← links)
- Current status and future prospects of chemotherapy for advanced hepatocellular carcinoma (Q38843057) (← links)
- Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment (Q38864396) (← links)
- Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial. (Q38887417) (← links)
- Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma (Q38923977) (← links)